id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-304584-jxha3rz8	Giacomo, Di	SARS-COV-2 infection in cancer patients undergoing checkpoint blockade: clinical course and outcome	2020-05-03		.txt	text/plain	425	35	51	The potential interplay between Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) infection and treatment with immune-checkpoint inhibitors (ICI) of cancer patients is presently unknown. Two subsequent swabs tested negative on April 3 and 4 for SARS-CoV-2 infection ( Figure 1) ; thus, the patient was considered cured from COVID-19 and she will resume ICI-therapy shortly. Undoubtedly, no general conclusion can be drawn from the positive outcome of these two patients on the reciprocal interplay between ICI therapy and SARS-CoV-2 infection. Nevertheless, these findings seem to suggest that treatment with ICI is a doable approach during the COVID-19 pandemic, and that SARS-CoV-2 infection does not seem to represent an obstacle to grant cancer patients the best treatment according to their clinical setting. SARS-CoV-2 infection was assessed by real-time-reverse-transcriptase-polymerasechain-reaction (rRT-PCR) testing positive (★) or negative (✪). SARS-CoV-2 infection was assessed by real-time-reverse-transcriptase-polymerase-chainreaction (rRT-PCR) testing positive (★) or negative (✪).	./cache/cord-304584-jxha3rz8.txt	./txt/cord-304584-jxha3rz8.txt